
Kurma Partners closes growth fund at €160m
The new fund is aimed at accelerating life sciences companies in advanced development stage, which is very similar to the recently presented EU...

ECBF oversubscribed closing at €300m
According to the industry experts, the biologisation of industrial production by means of sustainable bacterial-enzymatic or cell-culture-based...

Meat consumption must fall by at least 75 percent
The study from lead author Prof. Dr Matin Qaim reviews the current state of research on various aspects of meat consumption. In addition to the...

Moderna wants to extent its European footprint
According to the 10-year old biotech company local commercial presences are to be established in Belgium, Denmark, the Netherlands, Norway, Poland,...

Bayer invests into synthetic TCRs for cell therapy
Sometimes it's not bad to have old contacts like Jak Knowles, CEO of Boston-based Affini-T Therapeutics Inc., which left stealth mode at the J.P....

Vigeneron updates gene therapy collab with Daiichi Sankyo
Under the new agreement, Planegg-based AAV specialist ViGeneron GmbH will provide its novel engineered recombinant adeno-associated virus vectors...

Sanofi bags €300m from US investor Blackstone
French Sanofi has secured €300m from US equity financing specialist Blackstone Life Sciences to accelerate pivotal studies of its subcutanous...